SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-17-002505
Filing Date
2017-10-27
Accepted
2017-10-27 16:15:08
Documents
6

Document Format Files

Seq Description Document Type Size
1 sc13da511338002_10272017.htm SC 13D/A 371279
2 ex991to13da511338002_102717.htm EX-99.1 13600
3 ex992to13da511338002_102717.htm EX-99.2 14886
4 ex993to13da511338002_102717.htm EX-99.3 14611
5 ex994to13da511338002_102717.htm EX-99.4 16676
6 ex995to13da511338002_102717.htm EX-99.5 15387
  Complete submission text file 0000921895-17-002505.txt   447854
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Subject) CIK: 0000704562 (see all company filings)

IRS No.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: SC 13D/A | Act: 34 | File No.: 005-37393 | Film No.: 171159602
SIC: 2834 Pharmaceutical Preparations

Mailing Address 230 SOUTH LASALLE STREET 400 CHICAGO IL 60604
Business Address
STAFFORD JOHN S III (Filed by) CIK: 0001218981 (see all company filings)

Type: SC 13D/A